SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-12-004332
Filing Date
2012-08-10
Accepted
2012-08-10 08:00:39
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0612_soligenix.htm 10-Q 654358
2 CERTIFICATION f10q0612ex31i_soligenix.htm EX-31.1 14131
3 CERTIFICATION f10q0612ex31ii_soligenix.htm EX-31.2 13827
4 CERTIFICATION f10q0612ex32i_soligenix.htm EX-32.1 5876
5 CERTIFICATION f10q0612ex32ii_soligenix.htm EX-32.2 5902
  Complete submission text file 0001213900-12-004332.txt   3700924

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sngx-20120630.xml EX-101.INS 538273
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sngx-20120630.xsd EX-101.SCH 24810
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sngx-20120630_cal.xml EX-101.CAL 28711
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sngx-20120630_def.xml EX-101.DEF 83286
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sngx-20120630_lab.xml EX-101.LAB 224379
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sngx-20120630_pre.xml EX-101.PRE 151486
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 121022564
SIC: 2834 Pharmaceutical Preparations